Pharmacists and Pharmacies

Spaces are Available for Thought Leaders and Scholars in the Following Categories

National and State-Level Pharmacy Associations

Benefits of Participating

Help address the $528 billion dollar problem of non-optimized medication therapies that is adversely affecting the health and wellbeing of tens of millions of people in the US; help develop transformational practice, payment, technology and measurement models that work for all stakeholders involved in delivering medications, vaccines, digital therapeutics and related therapies to US populations; make new connections; be recognized for leadership.

Who is Included

National and state-level associations representing US pharmacists and pharmacies are invited to participate as Institutional Study Partners. State pharmacy associations are invited to participate helping to lead state-level panels.

Large Pharmacy Organizations

Benefits of Participating

Help address a $528 billion dollar problem adversely affecting the health and wellbeing of tens of millions of people in the US; help develop transformational practice, payment, technology and measurement models that work for all stakeholders involved in delivering medications, vaccines, digital therapeutics and related therapies to US populations; make new connections; be recognized for leadership.

Who is Included

Large US pharmacy organizations with enough market power to help influence change in their relevant networks are invited to join as organizational study partners. These include:

  • Chain Pharmacies

  • Larger Independent Pharmacy Groups

  • Specialty Pharmacy Groups

  • Contract Pharmacy Groups

  • Telepharmacy companies

Senior Leaders, Designees and Support Staff

Benefits of Participating

Help address a $528 billion dollar problem adversely affecting the health and wellbeing of tens of millions of people in the US; help develop transformational practice, payment, technology and measurement models that work for all stakeholders involved in delivering medications, vaccines, digital therapeutics and related therapies to US populations; make new connections; be recognized for leadership.

Who is Included

Senior leaders able to speak for their institutions or organizations along with their designees and support staff are invited as participants and/or observers. The goal is to have senior leaders who can make strategic decisions for their organizations actively engaged to help achieve transformational action.

Titles along the following lines are welcome:

  • Board Member

  • President/CEO

  • Chief XYZ Officer (Medical, Pharmacy, Nursing, Quality, Strategy, Operations, etc.)

  • Senior Vice President / Vice President

  • Director

Senior leaders are welcome to invite designees to join or represent them. Support staff, assistants, and interns are also welcome to join as observers or proxies to assist in decision-making.

Researchers with Relevant Expertise

Who is Included

Established researchers with academic affiliations and relevant expertise in this area are encouraged to join. Assistance in facilitating "boats" and "sections", co-investigation opportunities, and other opportunities are available. Researchers working in foundations, associations or research divisions of organizations are also welcome.

Learn more here.